- MA, MB, ChB Cambridge University 1977
- MD Cambridge University 1987
- FRCPE 1994
- FRCP 1996
- British Myology Society Council member 2008
- Honorary Senior Lecturer
David Hilton-Jones qualified in medicine from Cambridge University and trained in Neurology in Oxford, London and Montreal. His abiding interest in neuromuscular disorders was initially triggered by working with John Morgan-Hughes (Queen Square) and cemented by working with George Karpati in Montreal. He runs a multidisciplinary team providing a clinical service for patients with neuromuscular disorders. His specific interest in myasthenia gravis resulted from his collaboration with John Newsom-Davis in Oxford, from whom he took over management of the Oxford Myasthenia Centre.
Major contributions in clinical research relating to myotonic dystrophy and inclusion body myositis. Extensive international collaborations with research laboratories relating to gene identification. Major neuromuscular teaching commitments to World Muscle Sociery, British Myology Society, and European Academy of Neurology
Mutational spectrum and phenotypic variability of VCP-related neurological disease in the UK.
Figueroa-Bonaparte S. et al, (2016), J neurol neurosurg psychiatry, 87, 680 - 681
Bending over forwards - to make a diagnosis.
Hilton-Jones D., (2016), Eur j neurol, 23, 993 - 994
A novel quantitative assay of mitophagy: Combining high content fluorescence microscopy and mitochondrial DNA load to quantify mitophagy and identify novel pharmacological tools against pathogenic heteroplasmic mtDNA.
Diot A. et al, (2015), Pharmacol res, 100, 24 - 35
Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland
Bansagi B. et al, (2015), Journal of neurology, 262, 1899 - 1908
Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland.
Bansagi B. et al, (2015), J neurol, 262, 1899 - 1908